HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer: NCT01631357.

AuthorsLiang Liu, Quanli Gao, Jingting Jiang, Junping Zhang, Xin Song, Jiuwei Cui, Yunbin Ye, Zhiyu Wang, Xinwei Zhang, Xiubao Ren
JournalSignal transduction and targeted therapy (Signal Transduct Target Ther) Vol. 5 Issue 1 Pg. 244 (10 19 2020) ISSN: 2059-3635 [Electronic] England
PMID33077722 (Publication Type: Letter, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Topics
  • Autografts
  • Carcinoma, Non-Small-Cell Lung (mortality, therapy)
  • Combined Modality Therapy
  • Cytokine-Induced Killer Cells (transplantation)
  • Female
  • Follow-Up Studies
  • Humans
  • Immunotherapy
  • Lung Neoplasms (mortality, therapy)
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: